Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Panion & BF Biotech Inc Announces New Drug Application for Nephoxil


Tuesday, 8 Oct 2013 08:51pm EDT 

Panion & BF Biotech Inc announced that it has authorize a United States-based company Keryx to filed new drug application (NDA) to Food and Drug Administration (FDA) for its new drug Nephoxil (named Zerenex in the United States), which is a kidney drug. 

Company Quote

304.0
10.18 +3.46%
19 Dec 2014